Seizure News and Research

Latest Seizure News and Research

Common DNA variations underlie susceptibility to fever after smallpox vaccination

Their finding is the first to link individual differences written into the genetic code with a vaccine-related complication, albeit a mild one.

19 Jun 2007

Alzheimer's-associated enzyme beta-secretase can disrupt neural activity in the brain

An enzyme involved in the formation of the amyloid-beta protein associated with Alzheimer's disease can also alter the mechanism by which signals are transmitted between brain cells, the disruption of which can cause seizures.

19 Jun 2007

Study on B-cell depletion therapy

36% of patients with refractory systemic lupus erythematosus (SLE or lupus) remain well after undergoing B-cell depletion therapy (BCDT) without needing further standard immunosuppressive agents, according to a study presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.

17 Jun 2007

Millions of children denied cheap epilepsy drug worldwide

Millions of children with epilepsy in developing countries are being denied an effective drug that costs less than $3 a year, according to an editorial in the British Medical Journal.

14 Jun 2007

Anticonvulsant medication gabapentin effective for fibromyalgia pain

New research supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) shows that the anticonvulsant medication gabapentin, which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with the common, often hard-to-treat chronic pain disorder, fibromyalgia.

14 Jun 2007

After epilepsy surgery, quality of life related more to seizures than memory

Epilepsy surgery can eliminate seizures for 60 to 85 percent of people with temporal lobe epilepsy who do not respond well to medications.

5 Jun 2007

Gabapentin reduces hot flashes in men receiving androgen deprivation therapy

North Central Cancer Treatment Group ( http://ncctg/ ) researchers based at Mayo Clinic ( http://www.mayo.edu/ ) in Rochester, Minn., have discovered that low doses of a drug used to prevent epileptic seizures and to treat nerve pain caused by shingles substantially reduces hot flashes in patients who are undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.

5 Jun 2007

China in denial over toxic toothpaste

Authorities in China have called warnings about Chinese-made toothpaste by the U.S. Food and Drug Administration (FDA) both unscientific and irresponsible.

3 Jun 2007

Wide range of sleep-related disorders associated with abnormal sexual behaviors, experiences

A paper published in the June 1st issue of the journal SLEEP is the first literature review and formal classification of a wide range of documented sleep-related disorders associated with abnormal sexual behaviors and experiences.

3 Jun 2007

Better understanding of deep brain stimulation

Brain "pacemakers" that have helped ease symptoms in people with Parkinson's disease and other movement disorders seem to work by drowning out the electrical signals of their diseased brains.

1 Jun 2007

Overdiagnosis of congenital long QT syndrome (LQTS)

Congenital long QT syndrome (LQTS) can be lethal if not diagnosed -- yet recent increased awareness of the disorder may lead to diagnosing patients when they don't have the syndrome and then prescribing treatments that restrict patients' lifestyles, a new Mayo Clinic study shows.

1 Jun 2007

Advances in epilepsy treatment

Epilepsy and seizures affect 2.5 million Americans, 181,000 new cases of epilepsy are diagnosed every year, and the disorder incurs an estimated $12.5 billion in annual direct and indirect costs.

1 Jun 2007

Common antipsychotic drug for methamphetamine overdose may damage brain cells

A common antipsychotic drug used in emergency rooms to treat methamphetamine overdose damages nerve cells in an area of the brain known to regulate movement, a new study shows.

30 May 2007

Researchers explore the glycosylation process

By studying the addition of sugars to proteins — a process called glycosylation — in the nervous system of insects, Temple University researcher Karen Palter believes she may be able to better understand neurodegenerative diseases in humans.

28 May 2007

Check and balance for neuron activity provides insight into schizophrenia, seizures

Two genes important for human development and implicated in cancer and schizophrenia also help keep a healthy balance between excitation and inhibition of brain cells, researchers say.

24 May 2007

Large trial to identify the long-term health effects of West Nile virus infection

UT Southwestern Medical Center has joined a national clinical trial to identify the long-term health effects of West Nile virus infection and to learn more about the disease's progression, symptoms and mortality.

18 May 2007

Celecoxib offers promise for premature babies

Scientists have found evidence that the cox-2 inhibitor celecoxib, a common pain reliever used to treat arthritis, may offer a new way to reduce the risk of the most common cause of brain damage in babies born prematurely.

18 May 2007

Electroconvulsive therapy helps patients with severe depression who don't respond to other treatments

Electroconvulsive therapy has been shown to be a highly effective, safe, and even life-saving treatment for persistent and severe depression, bipolar disorder, and schizophrenia.

8 May 2007

Popular epilepsy drug damages the unborn

A study by researchers in the United States has found that women who took an epilepsy drug during their pregnancy had a higher risk of giving birth to children with a lower IQ or with mental retardation.

7 May 2007

Reducing levels of the protein tau can prevent seizures and neurological deficits related to Alzheimer's disease

The findings, reported in the journal Science, demonstrate that when tau is removed from mice genetically engineered to simulate Alzheimer's disease, their memory function is retained and they live a normal lifespan. Reducing tau levels also made mice more resistant to epileptic seizures.

4 May 2007